Browse by Series:

Subcutaneous Rituximab: A New Approach to Treating FL

Insights From: Nathan Fowler, MD, University of Texas MD Anderson Cancer Center
Published: Thursday, Dec 28, 2017

Slider Left
Slider Right
View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Medical Crossfire®: Management of Adverse Events Associated with Therapies for Hematological Disorders: Nurses' PerspectiveApr 21, 20182.0
Community Practice Connections™: Oncology Best Practice™: Choosing Therapies for Patients with EGFR-mutant Lung Cancers: More Options... More Decisions... Better OutcomesApr 27, 20182.0
Publication Bottom Border
Border Publication
x